Urea containing compounds that inhibit MAP kinases, pharmaceutical compositions including such compounds and methods for using these compounds to treat inflammatory diseases and cancer are described herein.
The invention relates to 9H-pyrrolo-dipyridine derivatives of formula I, processes for preparing them, pharmaceutical compositions containing them and their use as radiopharmaceuticals in particular as imaging agents for the detection of Tau aggregates.
本发明涉及式 I 的 9H-pyrrolo-dipyridine 衍生物、其制备工艺、含有它们的药物组合物以及它们作为放射性药物的用途,特别是作为检测 Tau 聚集体的成像剂。
9H-PYRROLO-DIPYRIDINE DERIVATIVES
申请人:UCB Biopharma SRL
公开号:EP3253762B1
公开(公告)日:2021-05-05
[EN] UREA DERIVATIVES AS INHIBITORS OF MAP KINASES<br/>[FR] DÉRIVÉS D'URÉE SERVANT D'INHIBITEURS DE MAP KINASES
申请人:LOCUS PHARMACEUTICALS INC
公开号:WO2010019930A1
公开(公告)日:2010-02-18
Urea containing compounds that inhibit MAP kinases, pharmaceutical compositions including such compounds and methods for using these compounds to treat inflammatory diseases and cancer are described herein.
[EN] 9H-PYRROLO-DIPYRIDINE DERIVATIVES<br/>[FR] DÉRIVÉS DE 9H-PYRROLO-DIPYRIDINE
申请人:UCB BIOPHARMA SPRL
公开号:WO2016124508A1
公开(公告)日:2016-08-11
The invention relates to 9H-pyrrolo-dipyridine derivatives of formula I, processes for preparing them, pharmaceutical compositions containing them and their use as radiopharmaceuticals in particular as imaging agents for the detection of Tau aggregates.